Friday, September 20, 2019

MORE NEWS

FDA approves oral diabetes drug from Novo NordiskThe U.S. Food and Drug Administration on Friday approved an oral version of Novo Nordisk's diabetes drug semaglutide, a boost for the Danish drugmaker, which hopes to transform the market by offering patients a noninjectable treatment.




from Yahoo News - Latest News & Headlines https://ift.tt/2ABqa4O

Share:

0 comments:

Post a Comment

Translate

ABOUT

THIS BLOG DISPLAYS ONLINE IMPORTANT NEWS OF USA.

Unordered List

Support